#FDA released this week to advance the development of novel treatments for neurological conditions; part of the agency’s broader effort to modernize FDA’s new drug review programs: http://go.usa.gov/xn6Ja
BLT Price at posting:
22.0¢ Sentiment: Hold Disclosure: Held
